2011
DOI: 10.1016/s1473-3099(11)70245-6
|View full text |Cite
|
Sign up to set email alerts
|

Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial

Abstract: Medical Research Council, UK, and Rockefeller Foundation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
65
1

Year Published

2012
2012
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(68 citation statements)
references
References 35 publications
2
65
1
Order By: Relevance
“…The number of patients given prophylaxis in order to prevent one case of cryptococcal disease was 45. There was a decrease in cryptococcalassociated death, an effect on hospitalization and all-cause mortality [100]. This result is consistent with data from randomized controlled trials utilizing antifungal therapy (fluconazole and itraconazole) for the primary prevention of cryptococcal disease among adults with CD4 cell counts < 150 cells/mm 3 [33,101].…”
Section: Prophylaxissupporting
confidence: 84%
See 1 more Smart Citation
“…The number of patients given prophylaxis in order to prevent one case of cryptococcal disease was 45. There was a decrease in cryptococcalassociated death, an effect on hospitalization and all-cause mortality [100]. This result is consistent with data from randomized controlled trials utilizing antifungal therapy (fluconazole and itraconazole) for the primary prevention of cryptococcal disease among adults with CD4 cell counts < 150 cells/mm 3 [33,101].…”
Section: Prophylaxissupporting
confidence: 84%
“…One approach is to administer prophylaxis to all at-risk patients. This strategy has been evaluated in adult patients in a prospective, double-blind, randomized trial with CD4 cell counts < 200 cells/mm 3 [100]. The number of patients given prophylaxis in order to prevent one case of cryptococcal disease was 45.…”
Section: Prophylaxismentioning
confidence: 99%
“…The incidence of cryptococcal infection is likely to fall as 90–90–90 rolls out. Some countries use extensive fluconazole prophylaxis, as this strategy antedated screen and treat, and this is also effective in preventing cryptococcal meningitis and deaths [32]. However, the potential gains estimated here in terms of survival are probably conservative overall, given the baseline assumptions used.…”
Section: Cryptococcal Diseasementioning
confidence: 99%
“…We have assumed a conservative rate of 7% in those with CD4+ cell counts <100×10 6 /L [15,16]. In Uganda it was 1.1% of all HIV patients [17] and 12% in all HIV Sub Saharan Africa [18][19][20]. There is evidence that earlier screening and prophylactictreatment with fluconazole prevents cryptococcal meningitis infections in HIV patients [17] and is a less expensive therapy option [21][22][23].…”
Section: Fungal Infections Complicating Hiv/aidsmentioning
confidence: 99%